APA (7th ed.) Citation

Erhartova, D., Cahova, M., Dankova, H., Heczkova, M., Mikova, I., Sticova, E., . . . Trunecka, P. (2019). Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation. PLoS ONE, 14(11), 1. https://doi.org/10.1371/journal.pone.0224820

Chicago Style (17th ed.) Citation

Erhartova, Denisa, Monika Cahova, Helena Dankova, Marie Heczkova, Irena Mikova, Eva Sticova, Julius Spicak, Ondrej Seda, and Pavel Trunecka. "Serum MiR-33a Is Associated with Steatosis and Inflammation in Patients with Non-alcoholic Fatty Liver Disease After Liver Transplantation." PLoS ONE 14, no. 11 (2019): 1. https://doi.org/10.1371/journal.pone.0224820.

MLA (9th ed.) Citation

Erhartova, Denisa, et al. "Serum MiR-33a Is Associated with Steatosis and Inflammation in Patients with Non-alcoholic Fatty Liver Disease After Liver Transplantation." PLoS ONE, vol. 14, no. 11, 2019, p. 1, https://doi.org/10.1371/journal.pone.0224820.